Takeda logo

ASH

Takeda Oncology at 2022 American Society of Hematology

Welcome

Thank you for visiting the Takeda Oncology Newsroom to learn more about research that will be presented at this year’s American Society of Hematology (ASH) congress. At Takeda Oncology, we aspire to cure cancer with inspiration from patients and innovation from everywhere.

Patients with limited or ineffective treatment options motivate us every day. With those patients' needs in mind, we strive to identify promising scientific innovations and to speed the development of life-changing medicines with curative potential.


Resources

altText of the image

News Release

altText of the image

Accepted Abstracts

Teresa Bitetti

Article

altText of the image

Article

altText of the image

Innate Immunity

altText of the image

Oncology Pipeline

altText of the image

Scientific Platforms

altText of the image

Article

All trademarks are the property of their respective owners.

©2023 Takeda Pharmaceuticals U.S.A., Inc.

All rights reserved.   01/23